BioCryst and Idera Special Meetings to Be Held on July 10, 2018 New Clinical Data on Idera’s IMO-2125 Program Will Be Available Prior to Vote RESEARCH TRIANGLE PARK, N.C. & EXTON, Pa. --(BUSINESS WIRE)--Apr. 10, 2018-- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst”) and Idera

BioCryst Mails Letter to Stockholders Highlighting Compelling Upside Opportunity BioCryst Special Meeting of Stockholders Scheduled for May 9, 2018 RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Apr. 2, 2018-- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst”) today announced that it has